Insider Buying: Perrigo Company (NYSE:PRGO) EVP Purchases 700 Shares of Stock

Perrigo Company (NYSE:PRGO) EVP John Wesolowski acquired 700 shares of the firm’s stock in a transaction dated Thursday, December 14th. The stock was bought at an average cost of $85.80 per share, for a total transaction of $60,060.00. The purchase was disclosed in a document filed with the SEC, which is available through this link.

John Wesolowski also recently made the following trade(s):

  • On Thursday, December 7th, John Wesolowski sold 450 shares of Perrigo stock. The stock was sold at an average price of $83.09, for a total value of $37,390.50.
  • On Wednesday, November 29th, John Wesolowski sold 388 shares of Perrigo stock. The stock was sold at an average price of $87.20, for a total value of $33,833.60.

Perrigo Company (NYSE:PRGO) opened at $91.99 on Friday. The company has a market capitalization of $12,690.00, a price-to-earnings ratio of -10.04, a PEG ratio of 1.92 and a beta of 0.64. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.72 and a quick ratio of 1.24. Perrigo Company has a 1 year low of $63.68 and a 1 year high of $92.16.

Perrigo (NYSE:PRGO) last released its quarterly earnings results on Thursday, November 9th. The company reported $1.39 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.11 by $0.28. The firm had revenue of $1.22 billion during the quarter, compared to analyst estimates of $1.17 billion. Perrigo had a positive return on equity of 11.60% and a negative net margin of 26.28%. The business’s revenue for the quarter was down 2.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.65 EPS. research analysts anticipate that Perrigo Company will post 4.88 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 19th. Stockholders of record on Friday, December 1st were given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 0.70%. The ex-dividend date was Thursday, November 30th. Perrigo’s payout ratio is -6.99%.

Several research analysts have recently commented on the company. Cantor Fitzgerald set a $107.00 price objective on Perrigo and gave the stock a “buy” rating in a research note on Thursday, December 28th. Leerink Swann initiated coverage on Perrigo in a research report on Tuesday, January 2nd. They set a “market perform” rating and a $90.00 target price for the company. Canaccord Genuity set a $100.00 target price on Perrigo and gave the stock a “buy” rating in a research report on Monday, January 1st. Jefferies Group reiterated a “hold” rating and set a $81.00 target price on shares of Perrigo in a research report on Friday, November 10th. Finally, Oppenheimer initiated coverage on Perrigo in a research report on Monday, October 2nd. They set a “buy” rating and a $88.00 target price for the company. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and nine have issued a buy rating to the stock. Perrigo currently has an average rating of “Hold” and a consensus target price of $92.00.

Several institutional investors and hedge funds have recently added to or reduced their stakes in PRGO. Commonwealth Bank of Australia raised its position in shares of Perrigo by 13.8% in the 2nd quarter. Commonwealth Bank of Australia now owns 1,455 shares of the company’s stock worth $108,000 after acquiring an additional 176 shares in the last quarter. Bessemer Group Inc. raised its position in shares of Perrigo by 1,046.2% in the 2nd quarter. Bessemer Group Inc. now owns 2,235 shares of the company’s stock worth $169,000 after acquiring an additional 2,040 shares in the last quarter. Allianz Asset Management GmbH bought a new position in shares of Perrigo in the 3rd quarter worth $217,000. Conning Inc. bought a new position in shares of Perrigo in the 3rd quarter worth $219,000. Finally, BlueCrest Capital Management Ltd bought a new position in shares of Perrigo in the 2nd quarter worth $221,000. 83.29% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This story was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this story on another publication, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this story can be read at https://stocknewstimes.com/2018/01/12/perrigo-company-prgo-evp-john-wesolowski-buys-700-shares.html.

About Perrigo

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Insider Buying and Selling by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply